ALVO Alvotech
$4.06
Alvotech (ALVO) is confirmed to report earnings on August 19, 2026, after the market close. The consensus earnings estimate is a loss of $0.05 per share, and the stock has had a Post-Earnings Announcement Drift (PEAD) of +22.5% since its last earnings release on May 6, 2026.
Alvotech Missed Consensus Estimates, Guides In-line
Wednesday, May 6, 2026 · 4:30 PM ET
Earnings Date
2nd Quarter, Jun 2026
Aug 19
Wednesday · 4:30 PM ET
Earnings Whisper
-
vs ($0.05)
Rev est $99.24M
Volatility
Enter your expectations below to reveal the current volatility.
Trend Analysis
Expectation
Earnings
Price action
Signals
Score
Sentiment
Grade
Life Cycle
Call Analysis
Earnings-AVWAP
$3.65
Sign in or subscribe to unlock sentiment, short interest, and technical indicators.
Whisperings™
About Alvotech
Alvotech is a biotech company focused solely on the development and manufacture of biosimilar medicines for patients worldwide.
Sector
Healthcare
Industry
Biotechnology